SEC Form 4 · accession 0000899243-16-016293
Aldeyra Therapeutics, Inc. · ALDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Young
Officer — Chief Operating Officer
Period of report
Mar 16, 2016
Accepted (ET)
Mar 18, 2016 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001341235
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $4.59 | Mar 16, 2016 | A | 10,000 | A | — | Mar 16, 2026 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2016.